Headstart programme for COVID-19 solutions: Winners list

Climedo Health, Henisaja, Intrepida and ScintHealth will be awarded €50,000 Headstart grant to help alleviate the COVID-19 pandemic. 

This year EIT Health expanded the scope of the Headstart programme to assist in the immediate need for solutions to combat COVID-19, and has selected 21 startups that will develop products and services that will help Europe to contain, treat and manage the disease. Among them, 4 were chosen by EIT Health Germany.

On 19 May 2020 EIT Health Germany hosted the online pitch competition for the Headstart programs for COVID-19 solutions. 11 startups made it to the shortlist and pitched their projects in front of an expert jury, composed of Carina Benstöm ( RWTH Aachen) , Gabriele Pestlin (Roche Diagnostics), Juergen Simon ( Siemens Healthineers) and Thomas Hegendörfer (Johnson & Johnson Innovation). The jury selected 4 startups to be awarded the € 50,000 Headstart grant to help alleviate the COVID-19 pandemic. The selected startups will receive access to mentoring and business support to complete their project in the next 6 months.

The winning teams:

Climedo Health : Climedo’s eQuarantineDiary allows for consolidation of remotely collected patient data, giving researchers a holistic, safe, and affordable way of capturing and monitoring COVID-19-related clinical data.



Henisaja GmbH : Henisaja’s product is RAMPmedical, an evidence and AI-based decision-support software for therapy that brings scientific research results into medical practice to assist clinicians and improve patient quality of life.


Intrepida LLC : Intrepida provides, an AI-powered online platform that helps patients and health volunteers search for and connect with clinical trials for COVID-19 diagnostics, treatments and vaccines.



ScintHealth is working on minimising the spread of contagious diseases in healthcare facilities, using smart, ultraviolet C systems that reliably and quickly inactivate germs, including the coronavirus, thereby preventing harm to humans.


Congratulations to the winning teams!